Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Apim Therapeutics A/S
Headquarters: Trondheim, Norway
Website: http://www.apimtherapeutics.c...
Year Founded: 2009
Status: Private
BioCentury | Dec 2, 2022
Regulation
Dec. 1 Quick Takes: FDA approves Rigel, Forma therapy for AML
Plus: Pfizer, Roivant form new unit around ulcerative colitis target, China’s Trinomab raises over $100M and updates from Nordic-APIM, Nectin, NIST and more
BioCentury | Nov 11, 2022
Regulation
Nov. 10 Quick Takes: BrainStorm falls on refusal-to-file letter from FDA
Plus: AZ dropping U.S. plans for Vaxzevria and updates from Neuraxpharm, Minoryx and more
BioCentury | Apr 23, 2012
Emerging Company Profile
APIM: Besting the stress defense
APIM targeting cancer cell stress defenses to treat multiple myeloma
Items per page:
1 - 5 of 5